Visum Pharmaceutical Co.
Latest round
- Series B
Last raised
- May 2018
Total raised
- Undisclosed
Investors
- 2
About Visum Pharmaceutical Co.
,Ltd. operates as an innovative drug developer, integrating high-end oral solid dosage form development, production, export and sales. The company established 2 manufacturing centers, 2 research and development centers and 1 marketing center. There are 450 employees in the company. The company has passed GMP review by FDA 4 times and quality review by NMPA 3 times. The company has created a technology R&D platform for slow and controlled release micro-pills, slow and controlled release skeleton tablets, and insoluble drugs. The company develops more than 80 types of products including slow and controlled release formulations, insoluble drugs and other drugs. Products within include metoprolol succinate extended-release tablets, quetiapine fumarate extended-release tablets, fenofibrate tablets, nateglinide tablets, repaglinide tablets fenofibrate tablets, nateglinide tablets, repaglinide tablets, aspirin dipyridamole capsules. The company will focus on the continued research and development of high-end formulations and the construction of new cGMP workshops.
Who invested in Visum Pharmaceutical Co.
2 investors across 1 round
See all investors in Visum Pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 25, 2018
Amount
Undisclosed
Investors
Questions about Visum Pharmaceutical Co.
Who invested in Visum Pharmaceutical Co.?
Visum Pharmaceutical Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Visum Pharmaceutical Co. raised?
Visum Pharmaceutical Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Visum Pharmaceutical Co. last raise money?
Visum Pharmaceutical Co.'s most recent round on record is a Series B, in May 2018.
What does Visum Pharmaceutical Co. do?
Visum Pharmaceutical Co. is a pharmaceuticals company.
Where is Visum Pharmaceutical Co. headquartered?
Visum Pharmaceutical Co. is headquartered in Haikou, China.
Which VCs invest in companies like Visum Pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Visum Pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Visum Pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.